-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Alto Neuroscience, Lowers Price Target to $21

Benzinga·04/02/2026 13:08:35
Listen to the news
Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and lowers the price target from $22 to $21.